New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 17, 2014
10:11 EDTCMG, INFY, GOOG, GOOGL, SNDK, YHOO, BX, KSU, GILDHigh option volume stocks: CMG INFY GOOGL GOOG SNDK MAT YHOO BX KSU GILD
News For CMG;INFY;GOOG;GOOGL;SNDK;YHOO;BX;KSU;GILD From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | all recent news | >>
October 9, 2014
14:09 EDTINFYInfosys October 60 straddle priced for 6.1% move into Q2
11:43 EDTGILDStocks with call strike movement; GILD EWZ
Gilead (GILD) February 120 call option implied volatility increased 3% to 38, MSCI Brazil Index (EWZ) February 58 call option implied volatility increased 3% to 38 according to IVolatility.
11:42 EDTCMGRuby Tuesday surges after Q1 profit beats estimates
Subscribe for More Information
09:19 EDTSNDKSanDisk results should beat expectations, says RBC Capital
RBC Capital expects SanDisk to report stronger than expected results for its September quarter. The firm's estimates for SanDisk remain above those of the Street for the next few years because the firm is upbeat on the company's ability to move to higher margin markets. The firm keeps an $118 price target and Outperform rating on the shares.
08:57 EDTSNDKSanDisk's NAND ASPs trending below consensus, says ITG Research
ITG Research said SanDisk's NAND ASP's are trending below Q3 consensus of +.5% but sees bit consensus growth of +39% year-over-year as achievable.
08:40 EDTSNDKDiablo Technologies comments on Netlist injunction
Diablo Technologies commented on the announcement that Netlist (NLST) has filed a motion for preliminary injunction against the company and its technology partner SanDisk (SNDK), in an attempt to impede the manufacture and sale of the ULLtraDIMM product. Diablo stated, "Notably absent from Netlist's press release is the fact that their recent motion has abandoned much of their previous positioning. Netlist's recent amendments now limit their claims of lost sales to the NVvault. These changes can be attributed to Netlist's failure to substantiate claims in the so-called anonymous 'whistleblower' letter, on which they have based their case from the start. The request for a Preliminary Injunction will take months to resolve and Diablo will continue to deal with these baseless accusations in court. We view their latest move as a public relations stunt, which we will address in our existing claim against them." Diablo filed its defense and a counter claim against Netlist's unfair business practices on September 25.
08:28 EDTGILDGilead to be challenged by AbbVie in HCV near-term, says Bernstein
Subscribe for More Information
06:29 EDTGOOGIDC: Worldwide PC shipments down 1.7% in Q3, DigiTimes reports
Worldwide PC shipments are down 1.7% with 78.5M units shipped in Q3, reports DigiTimes, citing the IDC. Shipments in the US grew 4.3% to 17.3M, with growth centered from strong momentum in te portables category. Reference Link
06:26 EDTGOOGGoogle's tax arrangement facing new challenge by France, WSJ reports
Subscribe for More Information
October 8, 2014
16:26 EDTGILDOn The Fly: Closing Wrap
Subscribe for More Information
16:01 EDTGILDOptions Update; October 8, 2014
iPath S&P 500 VIX Short-Term Futures down 2.73 to 29.51. Option volume leaders: AAPL TSLA TWTR AMZN FB NFLX PBR AA CLF GILD according to Track Data.
15:49 EDTGILDAchillion, Gilead rise after late breaking abstract for AASLD posted
Shares of Achillion (ACHN) are higher after the company announced this morning that four abstracts have been accepted for presentation at The Liver Meeting, the annual meeting of the American Association for the Study of Liver Diseases. Among those four is a late breaker poster presentation providing updated results, including SVR12, from an ongoing Phase 2 proxy study evaluating Achillion's second-generation NS5A inhibitor, in combination with sofosbuvir, without ribavirin, for eight weeks of treatment in patients with treatment-na´ve genotype 1 chronic hepatitis C virus infection. Sofosbuvir is sold under the brand name Sovaldi by Gilead Sciences (GILD). In a note to investors, FBR Capital noted that the "surprise" late-breaking poster for the meeting showed a 100% cure rate for the combination therapy. In late afternoon trading, Achillion shares are up 10% to $10.74 while Gilead is up 4.3% to $108.78.
10:06 EDTKSUStephens transportation analysts hold an analyst/industry conference call
Subscribe for More Information
10:00 EDTSNDKOn The Fly: Analyst Initiation Summary
Subscribe for More Information
09:48 EDTGOOGGoogle says new movies can be pre-ordered, watched on first day of availibility
Subscribe for More Information
08:34 EDTBXWindy Cove Energy receives up to $700M from Blackstone for U.S. oil assets
Subscribe for More Information
07:46 EDTGOOGcomScore well positioned for change, says Brean Capital
Subscribe for More Information
07:43 EDTSNDKSanDisk initiated with a Buy at Ladenburg
Subscribe for More Information
07:18 EDTGILDInfectious Diseases Society of America to hold a conference
ID Week 2014 is being held in Philadelphia on October 8-12.
06:19 EDTYHOOYahoo lays off 400 employees in India, WSJ reports
Subscribe for More Information
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use